HansaBioMed
HansaBioMed Life Sciences is an Estonian life sciences tools company that manufactures and distributes extracellular vesicle and exosome research products, including purified and engineered EVs, TFF and SEC isolation consumables, and custom research services, serving academic and industrial researchers across 71 countries.
- Company typePrivate
- Founded2007
- HeadquartersTallinn, Estonia
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
HansaBioMed firmographics
Firmographics- Name
- HansaBioMed
- Legal name
- HansaBioMed Life Sciences OÜ
- Website
- https://hansabiomed.eu
- Company type
- Private
- Founded year
- 2007
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- HansaBioMed Life Sciences is an Estonian life sciences tools company that manufactures and distributes extracellular vesicle and exosome research products, including purified and engineered EVs, TFF and SEC isolation consumables, and custom research services, serving academic and industrial researchers across 71 countries.
- Ownership category
- akta.pro rank
HansaBioMed industry classification
Industry- Product category
- Life Sciences Research Products
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714), Biological Product (except Diagnostic) Manufacturing (325414), Analytical Laboratory Instrument Manufacturing (334516)
- SIC
- Services-Commercial Physical & Biological Research (8731), Biological Products, (No Disgnostic Substances) (2836), Laboratory Analytical Instruments (3826)
- akta.pro primary industry
- Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)
Keywords
Where HansaBioMed is headquartered
LocationHeadquarters
- HQ city
- Tallinn
- HQ country
- Estonia
- HQ region
- Europe
Offices1 record
Markets served
HansaBioMed business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure
Revenue model
- EV Research Products: Sale of purified extracellular vesicles, fluorescent EVs, lyophilized exosomes, bacterial EVs, and engineered EVs for research applications. Products sold in various formats (vials, kits) with prices ranging from €168 to €541 per unit.
- EV Isolation & Processing Equipment: Sale of TFF cartridges, SEC columns, immunobeads, and immunoplates for EV isolation and analysis. Includes reusable and single-use products.
- Research Services: Custom EV research services covering upstream preparation (material preparation from plants, bacteria/yeast, cell culture), EV purification (enrichment of EV subpopulations, small and large EV purification), and downstream analysis (EV cell uptake, omics, physical-chemical characterization).
- Global Distribution: Products distributed through 69 distributor partners across 71 countries, enabling international sales reach.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Purified Extracellular Vesicles - Lyophilized formats |
| Unit Pricing | Pay-as-you-go | Fluorescent EVs |
| Unit Pricing | Pay-as-you-go | EV Isolation Products - TFF Cartridges |
| Unit Pricing | Pay-as-you-go | SEC Columns - PURE-EVs |
| Unit Pricing | Pay-as-you-go | Immunobeads and Immunoplates |
| Other | Multi-year contract | Research Services |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels4 records
HansaBioMed product offering
Product offeringCore offering
HansaBioMed Life Sciences manufactures and sells extracellular vesicle (EV) and exosome research products, including purified and engineered EVs (lyophilized, fluorescent, bacterial), EV isolation tools (TFF cartridges, SEC columns, immunobeads, immunoplates), and custom research services spanning upstream preparation, purification, and downstream analysis. Products are sold to academic and industrial researchers globally for EV characterization, isolation, and engineering applications.
Product overview
HansaBioMed Life Sciences is an extracellular vesicle (EV) research products and services company headquartered in Tallinn, Estonia. The company offers a comprehensive portfolio of purified EVs, engineered EVs, EV isolation tools, and research services for academic and industrial researchers. The product portfolio centers on four main categories: (1) Purified EVs including lyophilized exosomes from various cell lines (HEK293, A549, HCT116, Mesenchymal Stem Cells) and biofluids (urine), as well as bacterial EVs from Lactobacillus and E. coli; (2) Engineered/Fluorescent EVs including FLUO-EVs expressing EGFP or mCherry fusion proteins with tetraspanins (CD9, CD63, CD81), and fluorescent labeled microvesicles from various cancer cell lines; (3) EV Isolation products including PURE-EVs size exclusion chromatography columns, miniPURE-EVs spin columns, immunobeads and immunoplates for EV capture, and TFF (tangential flow filtration) cartridges including TFF-MV, TFF-EVs Small, TFF-Easy, and the automated TFF-Flexi system; and (4) Services covering upstream preparation (cell culture, bacteria, yeast, plant), exosome purification, and downstream analysis (EV cell uptake, omics, physical-chemical characterization). The company operates with ISO 9001 certification and distributes to over 70 countries through a network of 69 distribution partners.
Differentiator
Problem solved
Functional benefit
Products and services
- Fluorescent EVs from HEK293 cells (FLUO-EVs)
Quantifiable outcome
- Long-term storage stability up to 36 months at 4°C for lyophilized EVs
- +2 more outcomes
Companies that use HansaBioMed
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles2 records
HansaBioMed technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
HansaBioMed partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- Enterprise Estonia - PANACEA/EVs ProjectcoreHansaBioMed was awarded a project grant from the PANACEA/EVs project funded by Enterprise Estonia, supporting EV-based therapeutics research.
- Global Distributor Partners (69 partners in 71 countries)coreDistribution partners across Europe (85), Asia Pacific (47), Oceania (4), South America (4), North America (3), and Africa & Middle East (2) enabling global market reach.
Scale indicators4 records
Recent moves5 records
Expansion highlights5 records
HansaBioMed competitors and assessment
Company assessmentDirect peers
- Miltenyi Biotec: Miltenyi Biotec offers EV isolation kits, microbead-based immunocapture (similar to HansaBioMed's CD63/TM9SF4 immunobeads), and cell-separation tools widely used in EV research workflows, overlapping directly on reagents and capture technology.
- System Biosciences (SBI): System Biosciences (SBI) is a specialized life-sciences tools vendor selling exosome/EV isolation kits, engineered/fluorescent EVs, and EV research reagents to academic and biotech customers, making it the closest direct competitor to HansaBioMed's core product line.
- Izon Science: Izon Science develops tunable resistive pulse sensing and qEV size-exclusion chromatography columns for extracellular vesicle characterization, directly comparable to HansaBioMed's PURE-EVs SEC columns and EV-Spinner concentration products.
- Cell Guidance Systems: Cell Guidance Systems provides exosome/EV research tools including isolation reagents, lyophilized exosomes, and engineered vesicles, targeting the same academic and translational research buyer as HansaBioMed.
Broad incumbents
- Lonza Group: Lonza is a global biopharma CDMO with EV/exosome manufacturing capabilities and a broader cell-and-gene therapy services portfolio; an established incumbent whose scale and regulatory expertise dwarfs HansaBioMed but covers a different commercial scope.
- Bio-Techne: Bio-Techne sells research reagents, antibodies, ELISA kits, and exosome/EV tools through its ProteinSimple and R&D Systems brands, providing broader reagent catalogs that intersect with HansaBioMed's EV reagent and immunobead offerings.
- Thermo Fisher Scientific: Thermo Fisher is the largest life-sciences tools supplier, offering tangential flow filtration systems, cell-culture reagents, and analytical instruments that broadly overlap with HansaBioMed's TFF cartridges and research-reagent portfolio across many adjacencies.
Emerging players
- NanoFCM: NanoFCM builds nano-flow cytometry platforms for single-EV analysis, an emerging complementary technology used by the same EV research buyers who purchase HansaBioMed's purified EVs and engineered FLUO-EVs.
- CD Bioparticles: CD Bioparticles produces and distributes exosome/EV reference standards and custom isolation services, an emerging player in the same EV reagent niche where HansaBioMed competes.
- ExoDx (Exosome Diagnostics): ExoDx develops exosome-based liquid biopsy diagnostics; while its primary business is clinical rather than research tools, it sources related EV capture and characterization methods relevant to HansaBioMed's immunobead/immunoplate product family.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
HansaBioMed social profiles
Digital presenceHansaBioMed compliance and trust
Trust signalCompliance1 record
HansaBioMed financial estimates
Financial estimateRevenue estimate
Valuation estimate
HansaBioMed leadership team
Management profileNumber of profiles
Profiles4 records
HansaBioMed funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
HansaBioMed M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about HansaBioMed
What does HansaBioMed do?
HansaBioMed Life Sciences manufactures and sells extracellular vesicle (EV) and exosome research products, including purified and engineered EVs (lyophilized, fluorescent, bacterial), EV isolation tools (TFF cartridges, SEC columns, immunobeads, immunoplates), and custom research services spanning upstream preparation, purification, and downstream analysis. Products are sold to academic and industrial researchers globally for EV characterization, isolation, and engineering applications.
Is HansaBioMed a public or private company?
HansaBioMed is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was HansaBioMed founded?
HansaBioMed was founded in 2007. It employs 11 to 50 people.
Where is HansaBioMed based?
HansaBioMed is headquartered in Tallinn, Estonia, in the Europe region.
How does HansaBioMed make money?
Four revenue lines are on record. EV Research Products are the primary driver. The others are EV Isolation & Processing Equipment, research Services and global Distribution.
Who are HansaBioMed's main competitors?
Direct peers on record are Miltenyi Biotec, System Biosciences (SBI), Izon Science and Cell Guidance Systems. Broad incumbents are Lonza Group, Bio-Techne and Thermo Fisher Scientific. Emerging players are NanoFCM, CD Bioparticles and ExoDx (Exosome Diagnostics).
Does HansaBioMed have an API?
No public API is recorded for HansaBioMed.
What industry is HansaBioMed in?
HansaBioMed's product category is Life Sciences Research Products. Its primary akta.pro industry code is HLAGAIAI, Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes). Its NAICS code is 541714 and its SIC code is 8731.